The HCV Treatment Revolution Continues: Resistance Considerations, Pangenotypic Efficacy, and Advances in Challenging Populations

Ira M. Jacobson, MD

Gastroenterology & Hepatology October 2016, Volume 12, Issue 10, Supplement 4 Ira M. Jacobson, MD Chair, Department of Medicine Icahn School of Medicine at Mount Sinai […]